Eculizumab and refractory membranoproliferative glomerulonephritis
This letter to the editor discusses the use of eculizumab in refractory membranoproliferative glomerulonephritis. The response appears to be dramatic.
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) Editorial |
| Sprache: | Englisch |
| Veröffentlicht: |
March 22, 2012
|
| In: |
The New England journal of medicine
Year: 2012, Jahrgang: 366, Heft: 12, Pages: 1165-1166 |
| ISSN: | 1533-4406 |
| DOI: | 10.1056/NEJMc1106619 |
| Online-Zugang: | Verlag, Volltext: http://dx.doi.org/10.1056/NEJMc1106619 Verlag, Volltext: https://doi.org/10.1056/NEJMc1106619 
|
| Verfasserangaben: | Seetha Radhakrishnan, Andrew Lunn, Michael Kirschfink, Paul Thorner, Diane Hebert, Valerie Langlois, Fred Pluthero, Christoph Licht |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1584418702 | ||
| 003 | DE-627 | ||
| 005 | 20230427161328.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 181126s2012 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1056/NEJMc1106619 |2 doi | |
| 035 | |a (DE-627)1584418702 | ||
| 035 | |a (DE-576)514418702 | ||
| 035 | |a (DE-599)BSZ514418702 | ||
| 035 | |a (OCoLC)1341024285 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Radhakrishnan, Seetha |e VerfasserIn |0 (DE-588)1172211957 |0 (DE-627)1040981267 |0 (DE-576)514418710 |4 aut | |
| 245 | 1 | 0 | |a Eculizumab and refractory membranoproliferative glomerulonephritis |c Seetha Radhakrishnan, Andrew Lunn, Michael Kirschfink, Paul Thorner, Diane Hebert, Valerie Langlois, Fred Pluthero, Christoph Licht |
| 264 | 1 | |c March 22, 2012 | |
| 300 | |a 2 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 26.11.2018 | ||
| 520 | |a This letter to the editor discusses the use of eculizumab in refractory membranoproliferative glomerulonephritis. The response appears to be dramatic. | ||
| 700 | 1 | |a Kirschfink, Michael |e VerfasserIn |0 (DE-588)120927152 |0 (DE-627)080974457 |0 (DE-576)292452411 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The New England journal of medicine |d Waltham, Mass. : MMS, 1928 |g 366(2012), 12, Seite 1165-1166 |h Online-Ressource |w (DE-627)266889484 |w (DE-600)1468837-2 |w (DE-576)075962454 |x 1533-4406 |7 nnas |a Eculizumab and refractory membranoproliferative glomerulonephritis |
| 773 | 1 | 8 | |g volume:366 |g year:2012 |g number:12 |g pages:1165-1166 |g extent:2 |a Eculizumab and refractory membranoproliferative glomerulonephritis |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1056/NEJMc1106619 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u https://doi.org/10.1056/NEJMc1106619 |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20181126 | ||
| 993 | |a Editorial | ||
| 994 | |a 2012 | ||
| 998 | |g 120927152 |a Kirschfink, Michael |m 120927152:Kirschfink, Michael |d 910000 |d 911600 |e 910000PK120927152 |e 911600PK120927152 |k 0/910000/ |k 1/910000/911600/ |p 2 | ||
| 999 | |a KXP-PPN1584418702 |e 3034033192 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"physDesc":[{"extent":"2 S."}],"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"name":{"displayForm":["Massachusetts Medical Society"]},"origin":[{"dateIssuedKey":"1928","publisher":"MMS ; MMS","dateIssuedDisp":"1928-","publisherPlace":"Waltham, Mass. ; Boston, Mass."}],"id":{"eki":["266889484"],"zdb":["1468837-2"],"issn":["1533-4406"]},"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"Eculizumab and refractory membranoproliferative glomerulonephritisThe New England journal of medicine","note":["Gesehen am 04.08.25"],"recId":"266889484","corporate":[{"display":"Massachusetts Medical Society","roleDisplay":"Herausgebendes Organ","role":"isb"}],"language":["eng"],"pubHistory":["198.1928 -"],"part":{"text":"366(2012), 12, Seite 1165-1166","volume":"366","extent":"2","year":"2012","issue":"12","pages":"1165-1166"},"titleAlt":[{"title":"NEJM"}],"title":[{"title_sort":"New England journal of medicine","title":"The New England journal of medicine","subtitle":"NEJM"}]}],"origin":[{"dateIssuedDisp":"March 22, 2012","dateIssuedKey":"2012"}],"id":{"eki":["1584418702"],"doi":["10.1056/NEJMc1106619"]},"name":{"displayForm":["Seetha Radhakrishnan, Andrew Lunn, Michael Kirschfink, Paul Thorner, Diane Hebert, Valerie Langlois, Fred Pluthero, Christoph Licht"]},"type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Gesehen am 26.11.2018"],"language":["eng"],"recId":"1584418702","title":[{"title_sort":"Eculizumab and refractory membranoproliferative glomerulonephritis","title":"Eculizumab and refractory membranoproliferative glomerulonephritis"}],"person":[{"family":"Radhakrishnan","given":"Seetha","display":"Radhakrishnan, Seetha","roleDisplay":"VerfasserIn","role":"aut"},{"given":"Michael","family":"Kirschfink","role":"aut","roleDisplay":"VerfasserIn","display":"Kirschfink, Michael"}]} | ||
| SRT | |a RADHAKRISHECULIZUMAB2220 | ||